Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations

被引:58
作者
Halseth, AE [1 ]
Ensor, NJ [1 ]
White, TA [1 ]
Ross, SA [1 ]
Gulve, EA [1 ]
机构
[1] Pharmacia Corp, Cardiovasc & Metab Dis, St Louis, MO 63167 USA
关键词
5 ' AMP-activated kinase; diabetes; skeletal muscle; triglycerides; Glut4;
D O I
10.1016/S0006-291X(02)00557-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme 5'AMP-activated protein kinase (AMPK) is activated by increases in intracellular AMP concentration through a complex interaction of phosphorylation and allosteric regulation. Actions of AMPK elucidated thus far suggest that AMPK may be a viable target for pharmacololgic intervention in type II diabetes. Activation of AMPK is believed to mediate both the acute increase in skeletal muscle glucose uptake during exercise, as well as the adaptive responses to chronic exercise such as regulation of expression of components of the muscle glucose uptake system. In addition. AMPK is known to inhibit key enzymes involved ill lipid and cholesterol synthesis, suggesting that activation of this kinase may also ameliorate dyslipidemia. To investigate the effects of AMPK activation in animal models of type II diabetes, db/db and ob/ob mice were administered 5-aminoimidazole-4-calbox-amide 1-beta-ribofuranoside (A1CAR) Subcutaneously either acutely (single injection) or m ice per clay for 8 days (chronic treatment). Blood glucose was lowered transiently in both db/db and ob/ob mice by acute A1CAR treatment, returning to basal levels similar to3 h after A1CAR administration. In response to chronic treatment, blood glucose (measured 18 h post-A1CAR administration) was significantly decreased in both mouse models when compared to vehicle control groups, with morning blood glucose values oil Day 8 being decreased similar to30-35% in both Mouse models. Chronic A1CAR administration also resulted in ail elevation of total Glut4 concentration in skeletal muscle from ob/ob mice, but not db/db mice. In contrast to the beneficial effects on glucose metabolism, A1CAR treatment of db/db and ob/ob mice led to approximately a 2.5-3-fold increase in serum triglyceride levels compared to vehicle-treated controls. These data Suggest that pharmacological activation of AMPK may enhance glucose uptake in individuals with type II diabetes, however, this benefit may be offset by the concomitant elevation in triglycerides. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:798 / 805
页数:8
相关论文
共 32 条
  • [1] Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats
    Bergeron, R
    Previs, SF
    Cline, GW
    Perret, P
    Russell, RR
    Young, LH
    Shulman, GI
    [J]. DIABETES, 2001, 50 (05) : 1076 - 1082
  • [2] Effect of AMPK activation on muscle glucose metabolism in conscious rats
    Bergeron, R
    Russell, RR
    Young, LH
    Ren, JM
    Marcucci, M
    Lee, A
    Shulman, GI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (05): : E938 - E944
  • [3] Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner
    Buhl, ES
    Jessen, N
    Schmitz, O
    Pedersen, SB
    Pedersen, O
    Holman, GD
    Lund, S
    [J]. DIABETES, 2001, 50 (01) : 12 - 17
  • [4] LIPOPROTEIN PROFILE CHARACTERIZATION OF THE KKA(Y) MOUSE, A RODENT MODEL OF TYPE-II DIABETES, BEFORE AND AFTER TREATMENT WITH THE INSULIN-SENSITIZING AGENT PIOGLITAZONE
    CASTLE, CK
    COLCA, JR
    MELCHIOR, GW
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02): : 302 - 309
  • [5] HEPATIC-METABOLISM OF GENETICALLY DIABETIC (DB-DB) MICE .1. CARBOHYDRATE-METABOLISM
    CHAN, TM
    YOUNG, KM
    HUTSON, NJ
    BRUMLEY, FT
    EXTON, JH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1975, 229 (06): : 1702 - 1712
  • [6] AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation
    Chen, ZP
    McConell, GK
    Michell, BJ
    Snow, RJ
    Canny, BJ
    Kemp, BE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (05): : E1202 - E1206
  • [7] Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase
    Fryer, LGD
    Hajduch, E
    Rencurel, F
    Salt, IP
    Hundal, HS
    Hardie, DG
    Carling, D
    [J]. DIABETES, 2000, 49 (12) : 1978 - 1985
  • [8] Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle
    Fujii, N
    Hayashi, T
    Hirshman, MF
    Smith, JT
    Habinowski, SA
    Kaijser, L
    Mu, J
    Ljungqvist, O
    Birnbaum, MJ
    Witters, LA
    Thorell, A
    Goodyear, LJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) : 1150 - 1155
  • [9] Hanefeld M, 2001, INT J CLIN PRACT, P19
  • [10] The AMP-activated protein kinase - Fuel gauge of the mammalian cell?
    Hardie, DG
    Carling, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (02): : 259 - 273